I am excited to share the news of this transaction.
teapawt.net/logicbio/status/157689…
We are excited to announce that we have entered into an agreement to be acquired by Alexion in a transaction that we hope will accelerate our mission to deliver genetic medicine to patients with rare diseases. Learn more in the press release issued today investor.logicbio.com/news-r…
Fred Chereau retweeted
Members of our CMC team are presenting at the #CHIBioprocessingSummit in Boston this week! Check out the full program agenda here: bioprocessingsummit.com/ @CHI_Healthtech
Fred Chereau retweeted
Genetic testing is an important tool used by many #genetic counselors to support the diagnosis of a range of #rarediseases. Visit @GlobalGenes’ resource center to learn more about the advantages of #genetictesting: resource-hub.globalgenes.org…
Fred Chereau retweeted
Wishing all the dads on our team and in our community a happy #FathersDay weekend!
Fred Chereau retweeted
Our CEO Fred Chereau shares insights on adeno-associated virus (AAV) delivery in #genetherapy in this @genengnews article: genengnews.com/topics/genome…
Fred Chereau retweeted
goodmenproject.com/everyday-… Here's a great example of one of our young adults living life to the fullest! #propionicacidemia @GoodMenProject
Fred Chereau retweeted
Our team will lead oral and poster presentations highlighting LogicBio’s #GeneRide technology & advancements in AAV manufacturing processes during the @ASGCTherapy 2022 Annual Meeting. For details, see our press release: bit.ly/3l37y5c #geneediting #genetherapy #ASGCT22
Fred Chereau retweeted
Today is #DNADay – did you know #rarediseases affect an estimated 25 to 30 million Americans? @genome_gov shares insights on the impact of rare, #genetic diseases and the need to expand and advance research: bit.ly/3udmX8p
Fred Chereau retweeted
#Tyrosinemia is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. If untreated, tyrosine and its byproducts build up in tissues and organs, which can lead to serious medical problems. bit.ly/3r5XTOr
Fred Chereau retweeted
As we advance preclinical research in #tyrosinemia, our team is focused on learning from community members to ensure their perspectives guide our work. Learn about the Network of Tyrosinemia Advocates’ efforts to improve support for individuals & families: notacares.org/
Fred Chereau retweeted
Interested in learning more about LogicBio®? Check out our corporate presentation from the #HCWCO Gene Therapy and Gene Editing Conference: bit.ly/3F6P5ND @HCWCO
Fred Chereau retweeted
“The love we have for our child is amazing and makes all of the challenges worth it.”
Thank you to the Farkas family for sharing your powerful #methylmalonicacidemia (MMA) journey with us. Read the Farkas’ MMA story here: bit.ly/3rhaDCo
Fred Chereau retweeted
March marks both #EmployeeAppreciationDay and #InternationalWomensDay! This month, we held an all-employee outing to celebrate the many accomplishments of our team members dedicated to making a positive difference for the #raredisease community.
Fred Chereau retweeted
In the most common form of #methylmalonicacidemia (MMA), a variant in a gene called MUT prevents the body from properly processing certain fats and proteins. As a result, toxic metabolites accumulate in the liver, muscle tissue and brain. Learn more: bit.ly/3ioVs5s
Fred Chereau retweeted
This #IWD, we are celebrating the achievements of women pioneers at LogicBio & in the broader #biotech space who have paved the way for future generations of women and girls to lend their vision and help build a healthier, more equitable society. bit.ly/3vyTSoW
Fred Chereau retweeted
Thank you to all who joined us in showing support for @OrganicAcidemia last month! In the year ahead, we look forward to seeing all the OAA has in store as we continue our collective work to build broader awareness of organic acidemias. oaanews.org/
Fred Chereau retweeted
Joy Wang, Principal Scientist, shares a message of support for the #raredisease community in honor of #RareDiseaseDay. @rarediseaseday
Fred Chereau retweeted
On #RareDiseaseDay, everyone at LogicBio came together to show their stripes while participating in a virtual event dedicated to learning from the #tyrosinemia community. Thank you to our guest speakers for sharing your stories & perspectives with our team! #ShowYourStripes
Fred Chereau retweeted
Megan Ericson, Senior Scientist, Preclinical and Translational Biomarkers, shares a message of support for the #raredisease community in honor of #RareDiseaseDay. @rarediseaseday
Fred Chereau retweeted
#RareDiseaseDay is almost here! Listen to inspiring stories from the global #raredisease community: rarediseaseday.org/ @rarediseaseday
